| 项目编号 |
PRJCA028385 |
| 项目标题 |
Efficacy of Cadonilimab and Anlotinib Combination in Treating Multiple Drug-Resistant Pulmonary Large Cell Neuroendocrine Carcinoma: Insights from a Case Report and Literature Review |
| 涉及领域 |
Medical |
| 数据类型 |
Genome sequencing
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
This study assesses the efficacy of different treatment approaches, such as the use of cadonilimab and anlotinib, by monitoring the patient's response through various cycles of treatment. This includes the use of computed tomography scans to evaluate treatment response. We believe that our study makes a significant contribution to the literature because the case report explores alternative treatment options for pulmonary large cell neuroendocrine carcinoma patients who have shown resistance to traditional programmed death 1 monoclonal antibodies and multiple chemotherapies. The use of cadonilimab and anlotinib in this context is highlighted, suggesting that this combination could be a potential treatment strategy. |
| 样品范围 |
human |
| 发布日期 |
2024-07-22 |
| 出版信息 |
| PubMed ID |
文章标题 |
杂志名称 |
Doi |
发表年份 |
| 39512499
|
Efficacy of cadonilimab and anlotinib combination in treating multiple drug‑resistant pulmonary large cell neuroendocrine carcinoma: A case report and literature review
|
Oncology Letters
|
10.3892/ol.2024.14773
|
2024
|
|
|
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| National Natural Science Foundation of China
|
|
82260498
|
|
| National Natural Science Foundation of China
|
|
82160471
|
|
| Quzhou City Qujiang District Life Oasis Public Welfare Service Center; Health Development Promotion Project - Cancer Research Project
|
|
BJHA-CRP-033
|
|
| Guangxi Medical and health key discipline construction project
|
|
-
|
|
| 2021 Guilin City Science Research and Technology Development Plan Project
|
|
20210227-7-9
|
|
| Beijing Xisike Clinical Oncology Research Foundation
|
|
Y-QL202101-0214
|
|
|
|
| 提交者 |
Feng
Xue (xuefeng_doctor@126.com)
|
| 提交单位 |
GuiLin Medical University |
| 提交日期 |
2024-07-22 |
